Why Are Sex Workers Being Banned From Participating in the International AIDS Conference? A Call to Action on Sex Work and HIV
In July, the International AIDS Conference is being held in the United States for the first time in over twenty years, after the successful repeal of the ban on HIV-positive foreign nationals entering the US. However, US immigration law still bars entrance to anyone who has engaged in sex work in the past 10 years — even if they have no criminal convictions or work in a country where it is legal. This exclusion will prevent many current and former sex workers from outside the US from attending the conference. Yet sex workers and their clients are two of the populations at greatest risk of HIV infection.
Without the input, knowledge, and resources of those most directly affected by the disease, there is no chance of stopping the AIDS epidemic. To hold the government accountable for its harmful policies and in solidarity with those unable to attend the conference, US-based sex workers and allies collaboratively drafted A Call to Change US Policy on Sex Work and HIV – in consultation with numerous sex workers and sex worker-lead organizations in the US and abroad. We invite all people committed to ending AIDS to endorse this statement.
Structural issues drive HIV within the sex sector — criminalization and stigma compound health disparities already affecting those on the wrong end of racial, economic, and gender inequality. But when sex workers design and lead HIV prevention efforts, receive services and resources, and are supported to address social injustice, sex workers have successfully curtailed the spread of AIDS.
No Clapping Matter: Antibiotic-Resistant Gonorrhea Is On the Way and We Are Not Prepared
“We think of gonorrhea as a funny infection—the clap—that doesn’t kill anybody. But the consequences of untreated gonorrhea are quite serious; infertility, increased risk of HIV, and a big impact on our national wallet…nothing to clap about there.”
Today, many in the public health community will admit that we collectively took our eyes off the ball because Neisseria gonorrhoeaeis a very clever bug that has developed the ability to resist nearly all of the antibiotics that have been thrown in its path. It has steadily developed resistance to entire classes of antibiotics—as early as the 1940s it was resistant to sulfanilamides, by the 1980s penicillins and tetracyclines no longer worked, and in 2007 the CDC stopped recommending the use of fluoroquinolones (the class of drugs that includes Cipro, which we may all remember as the thing to stockpile in case of an anthrax attack). Today, the only class of antibiotics that remains effective are cephalosporins, but its susceptibility to these drugs is declining rapidly in the United States and other countries have already seen cephalosporin-resistant cases.
In February the Centers for Disease Control and Prevention (CDC) sounded the alarm about this growing threat and suggested that we need to change the way we screen for and treat gonorrhea in this country in order to respond to this wily germ. Last week, the World Health Organization (WHO) released a statement on this issue and, more importantly, a global action plan for stemming the spread of drug-resistant gonorrhea. As the resistant cases emerge, it is a good time to look at how we got here and what we can do to ensure that gonorrhea does not become a major public health threat.